In the BioHarmony Drug Report Database

"Preview" Icon

Temoporfin

Foscan (temoporfin) is a small molecule pharmaceutical. Temoporfin was first approved as Foscan on 2001-10-24. It has been approved in Europe to treat head and neck neoplasms and squamous cell carcinoma.

 

Trade Name

 

Foscan
 

Common Name

 

temoporfin
 

ChEMBL ID

 

CHEMBL383675
 

Indication

 

head and neck neoplasms, squamous cell carcinoma
 

Drug Class

 

Benzoporphyrin derivatives

Image (chem structure or protein)

Temoporfin structure rendering